Paine Schwartz Partners, LLC (PSP), a US private equity firm and global leader in sustainable food chain investing, will make a strategic investment in Hendrix Genetics, a Netherlands-based multi-species animal genetics company. PSP and its affiliated co-investors will hold 50% ownership in Hendrix and investment firm NPM Capital, a shareholder in Hendrix since 2015, will sell its minority interest. Hendrix Genetics' Co-Founders, Thijs Hendrix and Antoon van den Berg, will also maintain a 50% ownership position in Hendrix.
The transaction is expected to close by the end of the first quarter of 2022, subject to regulatory approval and customary closing conditions. De Brauw and Kirkland & Ellis LLP served as legal counsel to PSP.